Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

Figure 3

Objective partial responses to cetuximab-based treatment in patients with KRAS- mutated tumors. (A) Pre- and post-cetuximab CT scan showing partial tumor response allowing surgical resection to be performed in patient 6. (B) Pre- and post-cetuximab CT scan demonstrating a major tumor response to cetuximab-based treatment in patient 7.

Back to article page